Dear IPCRG Colleague,
Find out what has been happening at IPCRG over the past few months and our plans for the rest of 2019.
|
|
|
The complex problems we face in tackling the causes of respiratory disease, such as improving diagnosis with limited resources, joining up care across primary and secondary care, and getting universal access to affordable medicines require strong partnerships across public and private sectors, country borders, professions and academic disciplines. This edition of our newsletter focuses on important new partnerships.
|
|
|
Federation of International Pharmaceutical Societies (FIP)
|
|
|
|
As part of our new partnership with FIP, IPCRG’s President, Ioanna Tsiligianni, was invited to present the challenges in community-based management of patients with respiratory disease as part of a high-level symposium on air pollution and respiratory health: emerging roles for community pharmacists at the FIP annual conference in Abu Dhabi.
|
|
Meanwhile, we are looking forward to our first ever Teach the Teacher programme for pharmacists in Porto in October. Chaired by Jaime Correia de Sousa, who co-created our Teach the Teacher format, we thank our new IPCRG community pharmacist master faculty of Darush Attar-Zadeh, Garry Macdonald, Ema Paulino, and Francesc Moranta Ribas, who will be running an Asthma Right Care programme for 30 pharmacist leaders from 11 countries.
Our objective is to strengthen national teaching competence to deliver IPCRG programmes by ensuring national leaders have both teaching and content knowledge. Our ambition is that they will then adapt the programme to their national context and lead a national roll-out.
To learn more about Asthma Right Care see www.ipcrg.org/asthmarightcare
|
|
|
|
This year we ran three sessions at WONCA Asia Pacific and WONCA Europe, as the Respiratory Special Interest Group including one innovative session where we collaborated with the other SIGs to run a session on multi-morbidity. Remember all our WONCA presentations are available at: https://www.theipcrg.org/display/TeachColleagues/WONCA+Presentations
|
|
|
Breathing & Living Well, The Importance of Primary Care, is the theme of the IPCRG 10th World Conference taking place at Croke Park, Dublin on the 28-30th May 2020.
|
|
|
We are working closely with our partners Primary Care Respiratory Society Ireland to deliver 10th IPCRG World Conference to meet the needs of Irish primary care and our global audience.
And for the first time, IPCRG is working in partnership with our members to build the conference programme. In addition to the usual call for scientific abstracts, we are inviting proposals for sessions from partner societies, research teams, primary/community care professionals, industry and patient/public representatives. We are looking for 20 conference sessions that will help us build a comprehensive, attractive and balanced programme. Our aim is to cover the most important issues affecting primary care today in low, middle- and high-income countries relating to the theme of Breathing and Living Well. We are particularly keen on submissions on hot topics, respiratory health and physical activity, holistic care including psychological interventions as well as the relationship between air pollution and health. Priority will be given to proposals that use the evidence to rise above local lessons to offer global perspectives.
Structured care
Following positive negotiations in Ireland, family physicians in Ireland will soon deliver a new contract with their government payor to provide structured care for older people with chronic diseases. Therefore we are strongly encouraging proposals for a session on structured care, exploring care models that incentivise outcome-based care for people with chronic diseases, particularly for people with multiple morbidities. Our preference would be for a session that includes examples from a number of countries. The focus should be on the practical realities of the organisation of care, rather than theoretical or conceptual models.
Types of sessions
All session proposals can be submitted as case study lectures, mini-plenaries, interactive workshops or as discussion groups. Each session should have 1-2 chairs and up to 4 speakers.
The deadline for online submissions is 31 October 2019. Results will be available by 27 January 2020.
Bursaries
For confirmed session speakers, there will be a bursary scheme for the conference that may cover travel and accommodation.
To view the Call for Sessions and the online session submission form, please go to www.ipcrg2020.org
Any questions can be sent to conferencedirector@theipcrg.org
|
|
We are also working hard with our colleagues in China on the 1st IPCRG International (China) conference that will take place 23-25 October 2020 in Beijing.
Colleagues with Chinese connections do get in touch!
|
|
|
Latest publications:
Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role? Eur Respir J 2019; 53: [https://doi.org/10.1183/13993003.01193-2018]
Vardavas CI, Kyriakos CN, Fernández E, et al. H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases. Eur Respir J 2019; 54: 1901417 [https://doi. org/10.1183/13993003.01417-2019].
|
|
|
IPCRG is one of the core organisations of the NIHR Global Health Research Unit on Respiratory Health (RESPIRE). This major international research initiative is funded by the UK’s National Institute of Health Research (NIHR) and run from the University of Edinburgh.
|
|
|
|
Our colleagues in Kuala Lumpur, led by one of IPCRG’s Board directors, Prof Ee Ming Khoo, hosted the annual scientific meeting of RESPIRE in September attended by over 80 colleagues from four countries including our colleagues from Bangladesh, Malaysia, India and Pakistan. IPCRG hosted a workshop on sustainability including how the research can address the Sustainable Development Goals (SDGs), and how to sustain respiratory research activity. See @RESPIREGlobal
|
|
|
IPCRG is leading on clinical engagement, communication and dissemination for the Breathe Well partnership. The partnership, which is led by the University of Birmingham and funded by the UK National Institute for Health Research, aims to foster research in primary care and the community to improve the diagnosis, management and prognosis of COPD patients in low and middle-income countries, where around 90% of COPD deaths occur.
|
|
|
|
Our IPCRG partners Brazil, Republic of North Macedonia and China are meeting exacting recruitment targets in their primary care case-finding studies; colleagues in Georgia have just completed a feasibility study on pulmonary rehabilitation. IPCRG is coordinating the development of stakeholder engagement plans with each country to ensure that policy-makers and clinical leaders are aware of the studies and are ready to incorporate positive findings. @BreatheWell_UoB
|
|
Global RECHARGE
We recently attended the annual meeting of RECHARGE to learn more about the approaches our four IPCRG country partners are taking to implementation of pulmonary rehabilitation in India, Sri Lanka, Uganda and Kyrgyzstan. IPCRG will be working with the Global RECHARGE team to support the roll-out of an educational package for PR to ensure fidelity to the evidence. @Global_RECHARGE
|
|
|
|
We thank AstraZeneca for their support for our Asthma Right Care programme and entrusting us to create a social movement that aims to disrupt thinking about current asthma care, and raise awareness about the over-reliance on symptom relief rather than tackling the underlying inflammation.
|
|
|
|
We have just agreed a new programme of work on multi-morbidity, supported by Associate Corporate Member Boehringer Ingelheim. This explores the value of primary care and the role of family physicians as expert generalists, and will offer practical tools and educational material for clinicians in managing people with respiratory disease and other long term conditions.
|
|
|
|
We will be publishing a revised version of our desktop helper on the appropriate use of inhaled corticosteroids in people with COPD and how to support withdrawal as part of our agreement with Associate Corporate Member Novartis.
|
|
|
|
With the financial support of GSK we are just moving into the second tier of our Teach the Teacher programme for children with asthma in Malaysia and Spain, following a successful Tier 1 master faculty meeting earlier this year. This will develop a cadre of national teachers who can then roll-out training across the country.
|
|
|
|
We thank all our industry partners for allowing us to control the content 100%, and for enabling us to reach more countries and more parts of global health systems with education which remains chronically underfunded by national governments and health payors.
|
|
|
To Bruce Kirenga, lead of our Ugandan group, who has just been elected as co-chair of the GACD Lung Disease Group.
|
|
|
Thank you and welcome to new colleagues
|
|
|
Sam Louw, our longstanding Business Manager has now left to pursue a new career as a swimming coach. We thank her wholeheartedly for her longstanding commitment to IPCRG and wish her well in her new life.
Welcome to our new joiners:
Nicola Connor has now been appointed as Business Manager – please use the same email as before: businessmanager@theipcrg.org;
Katy Whyte administration@theipcrg.org assists us on travel, communications and membership.
Eloise Street events@theipcrg.org has joined the meetings team and is working on the Pharmacist Teach the Teacher meeting and supporting our faculty for CARDPC conference in Beijing this November and for our China 2020 meeting.
|
|
Please share this newsletter with your colleagues and community.
Ioanna Tsiligianni Siân Williams
President IPCRG CEO IPCRG
|
|
Save the Date
The IPCRG 10th World Conference will be in Dublin 28-30 May 2020
|
|
|
|
|
